Humalog, Humalog Mix, NovoLog, and NovoLog Mix are all approved for use in adults with type 1 or type 2 diabetes
And we can be your support system
Innovative bioactive nanofibrous materials combining medicinal and aromatic plant extracts and electrospinning method
Tirzepatide, a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management, has generated interest for addressing metabolic complications in thyroid patients
Learn how it works, its potential benefits, safety considerations, and what research currently reveals before considering its use
BPC-157 studies listed on PubMed consistently show positive results